Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001415889-23-002954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | HALO | LaBrosse Nicole | SVP, CFO | S - Sale+OE | $49.26 | -2,525 | 9,066 | -22% | -$124.4K |
| D | 2023-02-21 | 2023-02-16 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +5,094 | 11.6K | +78% | $0 |
| DM | 2023-02-21 | 2023-02-16 | HALO | LaBrosse Nicole | SVP, CFO | A - Grant | $0.00 | +82.4K | 21.3K | New | $0 |
| D | 2023-02-21 | 2023-02-16 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -5,094 | 15.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | S | D | 2,525 | $49.26 | 9,066 | D | — | — | (F1) The reported disposition of 2,525 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2023-02-16 | M | A | 5,094 | $0.00 | 11,591 | D | — | — | |
| 3 | Derivative | Option to Purchase Common Stock | 2023-02-16 | A | A | 61,061 | $0.00 | 61,061 | D | $49.26 · 2024-02-16 to 2033-02-16 | 61,061 Common Stock | (F3) This option vests one-fourth on such date and then 1/48th monthly thereafter. |
| 4 | Derivative | Restricted Stock Units | 2023-02-16 | M | D | 5,094 | $0.00 | 15,279 | D | $0.00 · — to — | 5,094 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 5 | Derivative | Restricted Stock Units | 2023-02-16 | A | A | 21,316 | $0.00 | 21,316 | D | $0.00 · 2024-02-16 to — | 21,316 Common Stock | (F4) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. |